Skip to main content

Caption Management, LLC

Source: SEC Form 13F · as of Mar 2026

Caption Management, LLC holds 51 biotech & pharma companies tracked by BioSniper, totaling $163.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

51

Total value held

$163.2M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Immunocore Holdings plc (IMCR)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
IMCRImmunocore Holdings plc661,786$20.0M
CYTKCYTOKINETICS INC245,000$16.1M
ELVNEnliven Therapeutics, Inc.370,000$14.5M
SLNOSOLENO THERAPEUTICS INC420,143$14.1M
CNTACentessa Pharmaceuticals plc274,116$10.9M
ANIPANI PHARMACEUTICALS INC135,890$10.4M
CMPSCOMPASS Pathways plc1,610,130$8.9M
TEVATeva Pharmaceutical Industries Limited280,058$8.4M
AVTXAvalo Therapeutics, Inc.455,000$6.8M
ROIVRoivant Sciences Ltd.219,800$6.1M
ADMAADMA BIOLOGICS, INC.660,000$5.9M
QUREuniQure N.V.303,231$5.0M
OCULOCULAR THERAPEUTIX, INC382,759$3.2M
BMRNBIOMARIN PHARMACEUTICAL INC55,300$3.1M
LRMRLarimar Therapeutics, Inc.635,024$2.9M
CTMXCytomX Therapeutics, Inc.573,224$2.7M
ACADACADIA PHARMACEUTICALS INC120,877$2.7M
ZVRAZEVRA THERAPEUTICS, INC.255,236$2.4M
ASMBASSEMBLY BIOSCIENCES, INC.81,841$2.3M
RNAAtrium Therapeutics Inc.103,592$1.4M
XERSXeris Biopharma Holdings, Inc.205,000$1.2M
PGENPRECIGEN, INC.306,616$1.2M
IONSIONIS PHARMACEUTICALS INC15,591$1.2M
STOKStoke Therapeutics, Inc.35,174$1.1M
DSGNDesign Therapeutics, Inc.86,708$923K
VRDNViridian Therapeutics, Inc.\DE45,127$883K
COGTCogent Biosciences, Inc.20,000$770K
TVTXTravere Therapeutics, Inc.25,000$743K
ONCBeOne Medicines Ltd.2,300$683K
DFTXDefinium Therapeutics Inc.33,758$638K
BHVNBiohaven Ltd.75,339$637K
NAMSNEWAMSTERDAM PHARMA CO N.V.19,507$624K
ARDXARDELYX, INC.104,200$624K
OLMAOlema Pharmaceuticals, Inc.35,000$522K
BCAXBicara Therapeutics Inc.23,000$457K
ALMSALUMIS INC.20,000$441K
TLPHTALPHERA, INC.561,820$420K
AGIOAGIOS PHARMACEUTICALS, INC.12,349$418K
RCUSArcus Biosciences, Inc.16,033$346K
ALDXAldeyra Therapeutics, Inc.165,000$279K
HRTXHERON THERAPEUTICS, INC. /DE/313,681$251K
CATXPerspective Therapeutics, Inc.60,000$250K
XOMAXOMA Royalty Corporation7,433$233K
ALTAltimmune, Inc.74,438$229K
MAZEMaze Therapeutics, Inc.5,000$149K
CRBPCorbus Pharmaceuticals Holdings, Inc.6,470$61K
TECXTectonic Therapeutic, Inc.1,449$45K
BBIOBridgeBio Pharma, Inc.431$32K
ABEOABEONA THERAPEUTICS INC.4,874$22K
VTGNVistagen Therapeutics, Inc.14,664$8K
IBRXImmunityBio, Inc.1,000$8K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.